Insufficient scRNA-seq data for expression of FGFRL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3877.21 | 180 / 180 | 99% | 169.76 | 425 / 430 |
prostate | 98% | 2051.18 | 241 / 245 | 99% | 73.84 | 498 / 502 |
liver | 100% | 4207.84 | 226 / 226 | 96% | 39.16 | 389 / 406 |
kidney | 100% | 3543.07 | 89 / 89 | 95% | 33.75 | 853 / 901 |
stomach | 100% | 3151.83 | 358 / 359 | 93% | 63.45 | 267 / 286 |
thymus | 100% | 11623.62 | 653 / 653 | 91% | 114.46 | 550 / 605 |
pancreas | 100% | 5947.50 | 328 / 328 | 90% | 30.86 | 161 / 178 |
intestine | 90% | 1481.40 | 869 / 966 | 96% | 65.80 | 505 / 527 |
breast | 100% | 3804.19 | 458 / 459 | 81% | 24.93 | 908 / 1118 |
lung | 99% | 2432.69 | 572 / 578 | 78% | 26.31 | 903 / 1155 |
esophagus | 77% | 1474.15 | 1106 / 1445 | 89% | 40.99 | 163 / 183 |
brain | 96% | 3567.95 | 2548 / 2642 | 69% | 30.54 | 486 / 705 |
skin | 97% | 1991.28 | 1749 / 1809 | 63% | 35.75 | 298 / 472 |
bladder | 100% | 1758.43 | 21 / 21 | 58% | 27.24 | 293 / 504 |
uterus | 91% | 1753.79 | 154 / 170 | 59% | 26.85 | 270 / 459 |
adrenal gland | 100% | 8158.51 | 258 / 258 | 32% | 24.35 | 73 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 40.22 | 80 / 80 |
blood vessel | 100% | 4609.76 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 4622.51 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 1761.09 | 787 / 803 | 0% | 0 | 0 / 0 |
spleen | 95% | 1406.33 | 229 / 241 | 0% | 0 | 0 / 0 |
heart | 89% | 1812.62 | 768 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 6.87 | 14 / 45 |
peripheral blood | 26% | 311.49 | 244 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001501 | Biological process | skeletal system development |
GO_0098742 | Biological process | cell-cell adhesion via plasma-membrane adhesion molecules |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0003179 | Biological process | heart valve morphogenesis |
GO_0060539 | Biological process | diaphragm development |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0044291 | Cellular component | cell-cell contact zone |
GO_0030133 | Cellular component | transport vesicle |
GO_0008201 | Molecular function | heparin binding |
GO_0005007 | Molecular function | fibroblast growth factor receptor activity |
GO_0017134 | Molecular function | fibroblast growth factor binding |
GO_0042802 | Molecular function | identical protein binding |
Gene name | FGFRL1 |
Protein name | Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5) FGFRL1 protein Fibroblast growth factor receptor like 1 |
Synonyms | FHFR FGFR5 UNQ480/PRO943 |
Description | FUNCTION: Has a negative effect on cell proliferation. . |
Accessions | A0PJ49 D6REM7 ENST00000504138.5 ENST00000507339.5 Q8N441 ENST00000510644.6 ENST00000512174.1 ENST00000398484.6 ENST00000264748.6 D6RBN8 |